S. 705 · 119th Congress

Innovation in Pediatric Drugs Act of 2025

Introduced on Feb 25, 2025 by Jack Reed (D-RI). One cosponsor. Latest action (Feb 25, 2025): Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1347)

Stage
Introduced
Introduced
Feb 25, 2025
Cosponsors
1
1 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.

Subjects

  • Cancer
  • Child health
  • Congressional oversight
  • Drug safety, medical device, and laboratory regulation
  • Drug therapy
  • Government information and archives
  • Government studies and investigations
  • Medical research
  • Prescription drugs
  • Research administration and funding

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Jack ReedD-RISponsor

Republicans · 1

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Feb 25, 2025Introduced in Senate
  2. Feb 25, 2025 · SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1347)

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. ASSOCIATION FOR CLINICAL ONCOLOGY6 reports
    $1.8M reported (all issues)
  2. National Association of Pediatric Nurse Practitioners6 reports
    $144K reported (all issues)
  3. BIOTECHNOLOGY INNOVATION ORGANIZATION4 reports
    $6.4M reported (all issues)
  4. COLLEGE OF AMERICAN PATHOLOGISTS3 reports
    $491.9K reported (all issues)Federal contractor: COLLEGE OF AMERICAN PATHOLOGISTS$18M in contracts, FY2026AI match · 99%
  5. GLAXOSMITHKLINE LLC3 reports
    $130K reported (all issues)Federal contractor: GLAXOSMITHKLINE, LLC$39.8M in contracts, FY2026AI match · 99%
  6. HARMONY BIOSCIENCES, LLC3 reports
    $510K reported (all issues)Federal contractor: HARMONY BIOSCIENCES LLC$614.4K in contracts, FY2026AI match · 100%
  7. AMERICAN SOCIETY OF ANESTHESIOLOGISTS2 reports
    $520K reported (all issues)
  8. American Academy of Pediatrics2 reports
    $420K reported (all issues)Federal contractor: AMERICAN ACADEMY OF PEDIATRICS$442.6K in contracts, FY2026AI match · 100%
  9. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA2 reports
    $12.9M reported (all issues)
  10. GSK (fka GLAXOSMITHKLINE INC.)1 report
    $800K reported (all issues)
  11. National Organization for Rare Disorders, Inc. (NORD)1 report
    $50K reported (all issues)Federal contractor: THE NATIONAL ORGANIZATION FOR RARE DISORDERS INCAI match · 100%
  12. The Nemours Foundation - a Florida not-for-profit Corporation1 report
    $247.5K reported (all issues)

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 7, 2026 · loaded Oct 7, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 7, 2026 · loaded Oct 7, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.